The potential for complete automated scoring of the cytokinesis block micronucleus cytome assay using imaging flow cytometry

• Published in: Mutation research. Genetic toxicology and environmental mutagenesis Vol. 836; no. Pt A; pp. 53 - 64
• Main Authors: Rodrigues, Matthew A., Beaton-Green, Lindsay A., Wilkins, Ruth C., Fenech, Michael F.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.12.2018
• Subjects: Chemical genotoxins; Imaging flow cytometry; Lymphocytes; Micronucleus assay; Radiation biodosimetry; TK6 cells; NPB; L5178Y; C; BF; Imaging flow cytometry; CBPI; IFC; MONO; FP; BN; DSB; NDI; Lymphocytes; EMA; IDEAS; PBL; SDM; TK6; CBMN; MN; CCD; NBUD; POLY; TK6 cells; Chemical genotoxins; ISX; Radiation biodosimetry; Micronucleus assay; CBMN Cyt; RI; FISH; Cyt-B
• ISSN: 1383-5718; 1879-3592; 1879-3592
• DOI: 10.1016/j.mrgentox.2018.05.003

[Display omitted] •The CBMN cytome assay is typically performed by visual microscopy.•The assay includes three biomarkers of DNA damage (MN, NPB, NBUD).•The assay also includes three biomarkers of cytotoxicity (NDI, necrosis, apoptosis).•Automated microscopy or flow cytometry cannot score the full range of biomarkers.•Performing the assay by imaging flow cytometry may overcome these limitations. The lymphocyte Cytokinesis-Block Micronucleus (CBMN) assay was originally developed for the measurement of micronuclei (MN) exclusively in binucleated (BN) cells, which represent the population of cells that can express MN because they completed nuclear division. Recently the assay has evolved into a comprehensive cytome method to include biomarkers that measure chromosomal instability and cytotoxicity by quantification of nuclear buds (NBUDs), nucleoplasmic bridges (NPBs) and apoptotic/necrotic cells. Furthermore, enumeration of mono- and polynucleated cells allows for computation of the nuclear division index (NDI) to assess mitotic activity. Typically performed by manual microscopy, the CBMN cytome assay is laborious and subject to scorer bias and fatigue, leading to inter- and intra-scorer variability. Automated microscopy and conventional flow cytometry methods have been developed to automate scoring of the traditional and cytome versions of the assay. However, these methods have several limitations including the requirement to create high-quality microscope slides, lack of staining consistency and sub-optimal nuclear/cytoplasmic visualization. In the case of flow cytometry, stripping of the cytoplasmic membrane makes it impossible to measure MN in BN cells, calculate the NDI or to quantify apoptotic or necrotic cells. Moreover, the absence of cellular visualization using conventional flow cytometry, makes it impossible to quantify NBUDs and NPBs. In this review, we propose that imaging flow cytometry (IFC), which combines high resolution microscopy with flow cytometry, may overcome these limitations. We demonstrate that by using IFC, images from cells in suspension can be captured, removing the need for microscope slides and allowing visualization of intact cytoplasmic membranes and DNA content. Thus, mono-, bi- and polynucleated cells with and without MN can be rapidly and automatically identified and quantified. Finally, we present high-resolution cell images containing NBUDs and NPBs, illustrating that IFC possesses the potential for completely automated scoring of all components of the CBMN cytome assay.